Diabetes and Covid-19 Pandemic-A T1 Patient Perspective | Abstract
Journal of Diabetes & Metabolism

Journal of Diabetes & Metabolism
Open Access

ISSN: 2155-6156



Diabetes and Covid-19 Pandemic-A T1 Patient Perspective

Derek C Beatty*

How might we successfully treat diabetes patients who become seriously ill and hospitalised sufffering from Coronavirus and requiring ventillator breathing assistance?

Coronavirus, Covid-19 is the most feared pandemic ever experienced on a global scale with dramatic morbidity and is challenging to treat and overcome. Media reports suggest that 25% of patients who die from Coronavirus are elderly and have an underlying health condition, often diabetes.

Could inhaled therapy drug treatment delivered to Critical Care Patients with the Multisonic®Infracontrol Nebuliser lead to improved recovery and reduced morbidity?

Published Date: 2020-08-22; Received Date: 2020-07-03